Qube Research & Technologies (QRT)
PRME icon

Qube Research & Technologies (QRT)’s Prime Medicine PRME Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-94,670
Closed -$329K – 3989
2025
Q4 		$329K Buy
+94,670
New +$421K ﹤0.01% 2924

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PRME Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Prime Medicine (PRME) in Q1 2026, closing a stake of 94,670 shares — an estimated $329K sold.

Qube Research & Technologies (QRT) first reported a position in PRME in Q4 2025 and held it in 1 quarter. The position peaked at $329K in Q4 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Prime Medicine position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 94,670 Prime Medicine shares in Q1 2026, an estimated $329K.
  • Qube Research & Technologies (QRT) first reported a position in Prime Medicine in Q4 2025 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Prime Medicine position peaked at $329K in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.